Reuters logo
8 个月前
BRIEF-Allergan completes acquisition of Chase Pharmaceuticals
2016年11月22日 / 晚上9点32分 / 8 个月前

BRIEF-Allergan completes acquisition of Chase Pharmaceuticals

1 分钟阅读

Nov 22 (Reuters) - Allergan Plc

* Allergan acquires Chase Pharmaceuticals to expand CNS research and development pipeline and build on commitment to alzheimer's disease

* Deal for an upfront payment of $125 million

* Allergan to advance CPC-201 into Phase 3 registration study in 2017

* Deal includes additional potential milestone payments related to chase's lead compound, CPC-201, and certain backup compounds

* Allergan plc - Allergan to advance cpc-201 into phase 3 registration study in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below